Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas
© 2023 The Authors. Histopathology published by John Wiley & Sons Ltd..
AIMS: The reliable classification of type A versus type B3 thymomas has prognostic and therapeutic relevance, but can be problematic due to considerably overlapping morphology. No immunohistochemical markers aiding in this distinction have been published so far.
METHODS AND RESULTS: We identified and quantified numerous differentially expressed proteins using an unbiased proteomic screen by mass spectrometry in pooled protein lysates from three type A and three type B3 thymomas. From these, candidates were validated in a larger series of paraffin-embedded type A and B3 thymomas. We identified argininosuccinate synthetase 1 (ASS1) and special AT-rich sequence binding protein 1 (SATB1) as highly discriminatory between 34 type A and 20 type B3 thymomas (94% sensitivity, 98% specificity and 96% accuracy). Although not the focus of this study, the same markers also proved helpful in the diagnosis of type AB (n = 14), B1 (n = 4) and B2 thymomas (n = 10).
CONCLUSIONS: Mutually exclusive epithelial expression of ASS1 in 100% of type B3 thymomas and ectopic nuclear expression of SATB1 in 92% of type A thymomas support the distinction between type A and type B3 thymomas with 94% sensitivity, 98% specificity and 96% accuracy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Histopathology - 83(2023), 4 vom: 12. Okt., Seite 607-616 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bremmer, Felix [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 13.09.2023 Date Revised 13.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/his.14972 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358098823 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358098823 | ||
| 003 | DE-627 | ||
| 005 | 20231226074024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/his.14972 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358098823 | ||
| 035 | |a (NLM)37308176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bremmer, Felix |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2023 | ||
| 500 | |a Date Revised 13.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Histopathology published by John Wiley & Sons Ltd. | ||
| 520 | |a AIMS: The reliable classification of type A versus type B3 thymomas has prognostic and therapeutic relevance, but can be problematic due to considerably overlapping morphology. No immunohistochemical markers aiding in this distinction have been published so far | ||
| 520 | |a METHODS AND RESULTS: We identified and quantified numerous differentially expressed proteins using an unbiased proteomic screen by mass spectrometry in pooled protein lysates from three type A and three type B3 thymomas. From these, candidates were validated in a larger series of paraffin-embedded type A and B3 thymomas. We identified argininosuccinate synthetase 1 (ASS1) and special AT-rich sequence binding protein 1 (SATB1) as highly discriminatory between 34 type A and 20 type B3 thymomas (94% sensitivity, 98% specificity and 96% accuracy). Although not the focus of this study, the same markers also proved helpful in the diagnosis of type AB (n = 14), B1 (n = 4) and B2 thymomas (n = 10) | ||
| 520 | |a CONCLUSIONS: Mutually exclusive epithelial expression of ASS1 in 100% of type B3 thymomas and ectopic nuclear expression of SATB1 in 92% of type A thymomas support the distinction between type A and type B3 thymomas with 94% sensitivity, 98% specificity and 96% accuracy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a argininosuccinate synthetase 1 | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a mass spectrometry | |
| 650 | 4 | |a pathology | |
| 650 | 4 | |a special AT-rich sequence binding protein 1 | |
| 650 | 4 | |a thymoma | |
| 650 | 7 | |a Argininosuccinate Synthase |2 NLM | |
| 650 | 7 | |a EC 6.3.4.5 |2 NLM | |
| 650 | 7 | |a Matrix Attachment Region Binding Proteins |2 NLM | |
| 650 | 7 | |a SATB1 protein, human |2 NLM | |
| 700 | 1 | |a Bohnenberger, Hanibal |e verfasserin |4 aut | |
| 700 | 1 | |a Findeisen, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Welter, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a von Hammerstein-Equord, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Hinterthaner, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Denise |e verfasserin |4 aut | |
| 700 | 1 | |a Küffer, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Okada, Satoru |e verfasserin |4 aut | |
| 700 | 1 | |a Marx, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Ströbel, Philipp |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Histopathology |d 1985 |g 83(2023), 4 vom: 12. Okt., Seite 607-616 |w (DE-627)NLM000284408 |x 0309-0167 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2023 |g number:4 |g day:12 |g month:10 |g pages:607-616 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/his.14972 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2023 |e 4 |b 12 |c 10 |h 607-616 | ||